Weekly Psychedelic Links - July 2022

7.1.22

Cannabis

• Fentanyl-laced marijuana is a myth. It’s time to end the hype (Leafly)

• Medical Weed Cards No Longer Required in Virginia Starting July 1 (High Times)

• Hemp, CBD get permanent legal status in NC after 11th-hour rescue (MSN.com)

• Scientists find THC in over 60% of CBD products they tested — and that may be a huge problem (ZME Science)

• UN Report Dramatizes Uptick in Global Cannabis Use (High Times)

• Louisiana Governor Signs Bill Providing Medical Marijuana Workplace Protections For State Employees (Marijuana Moment)

• Maryland Court: Cops Can Stop, Question Someone Who Smells of Pot (High Times)

• Nevada Cannabis Consumption Lounges Could Go Live By End Of 2022 (Marijuana Moment)

• Edibles, beverages infused with cannabis ingredient THC become legal Friday in Minnesota (Star Tribune)

• Inside The Process To Legalize Recreational Cannabis In Germany (Forbes)

• California Bill to Require Cannabis Warnings About Mental Disorder Risks Advances (High Times)

• Pennsylvania Lawmakers Advance Medical Marijuana DUI Protections And Cannabis Banking Reform Bills (Marijuana Moment)

• Texas Supreme Court Bans Smokable Hemp Production, Sales (High Times)

• Montana Lawsuit Challenges Marijuana Ban In State’s Third-Largest City (Marijuana Moment)

• House Panel Approves Amendment to Protect State Legal Cannabis Programs (High Times)

• Feds Fund Development Of Hemp-Based, 3D-Printed Materials To Build Affordable Housing (Marijuana Moment)

• New Vermont Guidance Looks to Eliminate Plastic Waste From State’s Cannabis Industry (High Times)

• Cannabis users are at greater risk for emergency and inpatient care: study (Fox News)

Magic Mushrooms

• These Mormons Have Found a New Faith — in Magic Mushrooms (Rolling Stone)

• New Jersey Senate President Files Psilocybin Legalization Bill That Includes Home Grow Option, Unlike Current Marijuana Law (Marijuana Moment)

• Tryp Therapeutics Strengthens IP Portfolio with Provisional Patent Application for Binge Eating Disorder Treatment (Psychedelic Alpha)

• Digging Up Druggable Targets: Psilocybin Efficacy in a Model of OCD (Psychedelic Science Review)

MDMA

• First-of-its-kind MDMA group therapy trial set to commence (New Atlas)

• Over One Hundred Years of MDMA Research (Drug Science)

Ayahuasca

• How the Shipibo Came to Be the Most Common Group Serving Ayahuasca to Foreigners (DoubleBlind)

Peyote

• Decriminalize Nature Targets Peyote: Drug Reform or Settler Colonialism? (Chacruna)

• Big business could wipe out Mexico’s sacred psychedelic peyote cactus (openDemocracy)

Novel Psychoactive Substances

• How Did A Minnesota Honor Roll Student Die As Her Parents Were Sleeping Upstairs? (Oxygen)

Synthetic Cannabinoids

• A Loophole in Japan’s Weed Laws Is Getting Tens of Thousands High (VICE)

Miscellaneous

• Colorado Activists Turn In Signatures To Put Psychedelics Legalization And Therapeutic Psilocybin Program On Ballot (Marijuana Moment)

• War on drugs prolonged Colombia’s decades-long civil war, landmark report finds (The Guardian)

• Is there a future for psychedelic treatment in Saudi Arabia? (Arab News)

• Do Bad Psychedelic Patents Matter? (Lucid News)

• 4 Recommendations for Disability Inclusion in Psychedelic Therapy Research (Psychiatric Times)

7.8.22

Cannabis

• WNBA Star Brittney Griner Pleads Guilty To Cannabis Charge As Russia Calls Out U.S. Hypocrisy In Maintaining Criminalization (Marijuana Moment)

• Make no mistake, marijuana edibles are legal now in Minnesota (Leafly)

• Washington, D.C. Mayor Signs Medical Cannabis Self-Certification Bill (High Times)

• Pennsylvania Bill Gives Medical Cannabis Patients DUI Protection (High Times)

• Oklahoma: Advocates Turn in Signatures to Place Adult-Use Legalization Measure on November Ballot (NORML)

• Study Shows Flower Still Reigns Supreme in U.S., Canada as Consumer Favorite (High Times)

• Arkansas Activists Set To Turn In Double The Signatures Needed To Put Marijuana Legalization On Ballot (Marijuana Moment)

• Nebraska Medical Marijuana Activists Turn In Ballot Signatures After Campaign Suffers Legal Setback (Marijuana Moment)

• Albania Prompted to Implement Medical Cannabis Reform After U.N. Criticism (High Times)

• U.S. Army Wants To Make Sniper Uniforms Out Of Hemp (Marijuana Moment)

LSD

• A man whose daily headaches felt like an ice pick in his eyes says he tried 12 treatments but only found relief after taking LSD (Insider)

Magic Mushrooms

• New Study Shows Mood, Mental Health Improved by Microdosing Psilocybin (High Times)

• Indiana Nurse Faces Ten Years in Prison for Microdosing Psilocybin Mushrooms (Psychedelic Spotlight)

• Two Cancer Patients Battle to Make Psilocybin Accessible for Palliative Care (Scientific American)

• Rural Oregon counties are lining up against psilocybin launch (OPB)

MDMA

• Alexandria Ocasio-Cortez Pushes for Psychedelic Reform in Congress (DoubleBlind)

• GOP Congressman’s Amendment Would Direct Military To Study Psilocybin And MDMA Benefits For Service Members (Marijuana Moment)

DMT

• Algernon Pharmaceuticals Provides Update on Its Phase 1 DMT Stroke Study (Psychedelic Alpha)

Iboga

• ‘To Heal and to Care for’: Protecting Iboga and Indigenous Voices in the Face of Corporatisation (Volteface)

Novel Psychoactive Substances

• DEA Announces Hearing On Proposed Ban Of Five Psychedelic Compounds Following Significant Pushback (Marijuana Moment)

• Mindset Pharma Receives Allowance for Patent Application Covering its Short-Duration Novel Psychedelic Medications for The Treatment of Central Nervous System Disorders (Psychedelic Alpha)

Ketamine

• PharmaTher Announces Positive Results from Study For Ketamine Microneedle Patch (Psychedelic Alpha)

Miscellaneous

• The Never-Ending Psychedelic Trip of Michael Pollan (Rolling Stone)

• Journey Colab scores $12M to move psychedelics-based addiction treatment into clinic (Fierce Biotech)

• User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study (Drug Science)

• Tripping the Reward Circuit: Psychedelics for Substance Use Disorders (Psychedelic Science Review)

• Psychedelics Give a Glimpse of Enlightenment (Psychology Today)

7.15.22

Cannabis

• Feds Must Defend Historical Rationale Of Banning Guns For Medical Marijuana Patients, Revised Lawsuit Argues After SCOTUS Ruling (Marijuana Moment)

• ‘Green way of life’: Thailand sees cannabis boom after law change (Al Jazeera)

• Washington DC just legalized weed for all adults—but it’s locals only (Leafly)

• Oklahoma, North Dakota, Arkansas, and Nebraska submit signatures to put cannabis on November ballot (Leafly)

• Study Shows Decrease in Heavy Truck Crash Rates Since Cannabis Legalization (High Times)

• NYPD Will Keep Testing Officers For Marijuana, Reversing Course Hours After Announcing Policy Change Mandated By City (Marijuana Moment)

• Cannabis Laws in France Have Disproportionately Affected Muslims (High Times)

• New York Firefighters Won’t Be Tested For Marijuana, Department Says Following NYPD Leak (Marijuana Moment)

• Argentine Supreme Court Endorses Medical Cannabis Home Grow (High Times)

• Pennsylvania Governor Signs Marijuana Banking And Insurance Reform Bill Into Law (Marijuana Moment)

• Portland Weed Demand Hits Three-Year Low (High Times)

• Pennsylvania Police Arrested Over 13,000 People for Marijuana Possession in 2021 (NORML)

• The Fight for Medical Cannabis in Indonesia (High Times)

• Weed, Like Change, Nourishes The Soil To Regenerate The Cannabis Industry (Forbes)

LSD

• Why David Bowie wasn’t a fan of LSD (Far Out)

Magic Mushrooms

• DEA May Find Itself In Federal Court Again Over Refusal To Provide Psilocybin Access To Terminally Ill Patients (Marijuana Moment)

• Oregon therapeutic psilocybin program sparks some confusion (OPB)

MDMA

• World's first ecstasy 'shop' set to trial in the Netherlands (Mixmag)

• Luxury Champagne Recalled Again Over Ecstacy Contamination (Newsweek)

• MDMA: Rolling from Counterculture to the Clinic Counter (Psychedelic Science Review)

Ayahuasca

• Study suggests ayahuasca users tend to eat healthier, get more exercise, and experience physical and mental health benefits (PsyPost)

Ketamine

• PharmaTher Announces Notice of Allowance for U.S. Patent Covering Ketamine for the Potential Treatment of Parkinson’s Disease and Motor Disorders (Psychedelic Alpha)

Miscellaneous

• Ann Shulgin, Forerunner of Today's Psychedelic Re-Emergence, Dies at 91 (Transform Press)

• House Approves Marijuana And Psychedelics Amendments As Part Of Must-Pass Defense Bill (Marijuana Moment)

• What Ethnographers Have Learned from People Who Use Drugs (Undark)

• Inside the Chemistry Lab Where the MDMA Godfather Synthesized Novel Psychedelics (DoubleBlind)

• The Tory Leadership Candidates on Drugs (Volteface)

• Filament Health Issued Third Patent By United States Patent and Trademark Office (Psychedelic Alpha)

• Doctors Urge Access to Psychedelic Therapies in New Mexico (TIME)

• Can Psychedelics Treat Inflammation and Eye Disease? Eleusis Thinks So. (Lucid News)

• Villain Or Victim? Understanding The Role of Women In The Latin American Drug Trade (TalkingDrugs)

• San Francisco’s New DA Vows to Ramp Up City’s Drug War (Filter)

• The Battle for Psychedelic Patents (Psychedelic Spotlight)

• How To Become a Psychedelic Therapist (DoubleBlind)

• 5 Countries Where Psychedelics are Legal (Psychedelic Spotlight)

7.22.22

Cannabis

• Senate Leadership Introduces Legislation to End Federal Marijuana Prohibition (NORML)

• District of Columbia: Mayor Signs Legislation Prohibiting Most Employers from Discriminating Against Cannabis Consumers (NORML)

• Legal cannabis is producing more plastic waste than pot (Leafly)

• Colorado Company To Research Cannabis As A Treatment For Parkinson’s Disease (Forbes)

• Biden Says He’s ‘Working On’ Bill To Release Cannabis Inmates (High Times)

• Germany, Luxembourg, Malta And The Netherlands Discuss Marijuana Legalization At Historic Joint Meeting (Marijuana Moment)

• Colorado Springs Recreational Cannabis Initiative Qualifies for November Ballot (High Times)

• Minnesota Is Home To America's First Cannabis Disc Golf Course (MIX 108)

• House Passes Bill Permitting Weed Ads on TV and Radio (High Times)

• Colorado's New Lead Marijuana Monitor Treks Through Heavy Issues (Westword)

• Cannabis Telemedicine Launches in Montana (High Times)

• Montana Marijuana Businesses Face Seemingly Endless Cycle Of Local Votes On Allowing Them To Operate (Marijuana Moment)

• People Busted for Weed in the U.K. Could Lose Passports Under Proposed Rules (High Times)

• Missouri Marijuana Legalization Measure In Danger Of Not Qualifying For Ballot (Marijuana Moment)

• Denver officials want to save struggling cannabis delivery businesses (The Denver Post)

• Study Finds Australians Support Cannabis Use Over Smoking Tobacco (High Times)

• House Will Not Vote On Marijuana Amendments For Veterans And Public Housing Residents After Committee Snag (Marijuana Moment)

• Marijuana use is higher among US states that have legalized recreational cannabis use (News-Medical)

LSD

• The Doors of Expression: LSD Alters Epigenetics and Protein Induction (Psychedelic Science Review)

• Science Feature: MindMed’s LSD Trial for ADHD (Microdose)

• Watch John Lennon explain that 'Lucy in the Sky with Diamonds' was not about LSD (Far Out)

Magic Mushrooms

• The Sloppy Science of Psilocybin Microdosing Surveys (Psychedelic Spotlight)

• A single dose of psilocybin has long-lasting antidepressant-like effects in fruit flies (PsyPost)

• Restrictions on Psilocybin ‘Magic Mushrooms’ Are Easing as Research Ramps Up (Scientific American)

MDMA

• Patient safety issues halt trial for MDMA-assisted psychotherapy during Health Canada review (CBC)

• 'Corrective' measures ordered, but Health Canada says 2nd MDMA trial can continue (CBC)

DMT

• Teenager Used LSD And DMT To Help Overcome Trauma, Case Report Says (IFLScience)

Ayahuasca

• Churches sue to use hallucinogenic tea in religious practice (UPI)

• The Global Ayahuasca Boom: What About the Conservation of the Ayahuasca Vine? (Chacruna)

5-MeO-DMT

• The Story Behind a 1984 Hallucinogenic Pamphlet From Denton Is Just as Trippy as Its Subject (Dallas Observer)

Novel Psychoactive Substances

• Mydecine Files Full Patent Application Covering MYCO-006 Family of Novel Short-Acting MDMA Analogs (Psychedelic Alpha)

Synthetic Cannabinoids

• Weed vapes probably sending a toxic gas to your lungs, study finds (Salon)

• Cannabis getting stronger with synthetic versions added leading to psychosis, report warns (Independent.ie)

Ketamine

• Largest-ever clinical study of ketamine therapy shows that at-home model can be a safe, effective treatment for anxiety and depression; 62% fewer patients report suicidal ideation after four sessions (PR Newswire)

• Ketamine Beneficial For Treating Neonatal, And Pediatric Epilepsy: Study (Medical Dialogues)

Miscellaneous

• The Long, Strange Relationship Between Psychedelics and Telepathy (VICE)

• DEA Sued Over ‘Unlawful’ Delays On Psychedelic And Marijuana Public Records Requests Through FOIA (Marijuana Moment)

• Colorado Psychedelics Legalization Measure Qualifies for November Ballot (DoubleBlind)

• Keeping the Hippie Dream Alive (The New York Times)

• Accessibility Is Key for the Psychedelic Revolution (Pharmacy Times)

• Podcast aims to raise awareness about future of psychedelic treatments (CBC)

• Skip the trip – does the world need non-hallucinogenic psychedelics? (leafie)

• New Regulations for Psychedelics? Here's What Investors Need to Know (The Motley Fool)

7.29.22

Cannabis

• Weedmaps again advertising illegal marijuana retailers and products, complaints allege (Marijuana Business Daily)

• Singapore Executes Man for Cannabis Trafficking (High Times)

• House Passes Bipartisan Marijuana Research Bill, With Senate Expected To Send It To President Soon (Marijuana Moment)

• Zimbabwe OKs First Medicinal Cannabis Sales (High Times)

• Secret Australian marijuana facility exposes location after turning sky pink (The Washington Post)

• Biden Administration Proposes Prisoner Swap To Free Brittney Griner (High Times)

• Over 850 Doctors in Thailand Protest Pot Legalization (High Times)

• Senator Files Bill To Allow Marijuana Advertising On TV And Radio In Legal States (Marijuana Moment)

• The 'World's Biggest Cannabis Scam' Is Totally Unravelling (VICE)

• Bronx Cannabis Hub Fosters Opportunity in Communities Hit Hard by Arrests (Filter)

• Cannabis Users Less Likely to Face Complications After Spinal Fusion Surgery (High Times)

• 15 State Attorneys General File Brief Opposing Lawsuit To Help Put Medical Marijuana On Nebraska Ballot (Marijuana Moment)

• Thai businesses cash in on cannabis, from milk tea to toothpaste (Reuters)

• Missouri Marijuana Legalization Initiative Short Of Signatures Needed For Ballot In County Reviews (Marijuana Moment)

• New Hampshire stands alone in New England as only state without legal marijuana (WMUR)

LSD

• New Zealand Government Grants $650K For LSD Microdosing Trials (Benzinga)

• Operation Julie: Rural Wales LSD bust becomes a musical (BBC)

Magic Mushrooms

• DEA Sued Again Over Refusal To Allow Psilocybin Access For Patients Despite Federal Law (Marijuana Moment)

• Why some of Colorado’s foremost shrooms advocates won’t be voting to legalize psilocybin (The Denver Post)

• Legal psilocybin prescriptions in Canada (Drug Science)

• Project Solace: The World’s Largest Medical Psilocybin Access and Data Project (Psychedelic Spotlight)

• COMPASS Pathways launches phase II clinical trial of psilocybin therapy in anorexia nervosa (Psychedelic Alpha)

DMT

• U.S. Patent Grant to Strengthen Small Pharma’s DMT Patent Strategy With Injectable Formulation (Psychedelic Alpha)

Novel Psychoactive Substances

• DEA Cancels Proposed Ban Of Five Psychedelics, Giving Scientists More Time To Research Therapeutic Benefits (Marijuana Moment)

• Working with Indigenous allies is the ethical way to develop psychedelic-based pharmaceuticals (STAT News)

• Festival drugs: Warning over 'imposter' substances threat (BBC)

• Ecstasy for the 21st Century: Designer Drugs to Improve MDMA Therapy (Psychedelic Science Review)

Synthetic Cannabinoids

• Easy On The Eyes — This Company Reports Using a Unique Synthetic Cannabinoid Derivative To Treat Glaucoma (Benzinga)

Nitrous Oxide

• Doctors warn ‘dangerous’ laughing gas is becoming an ‘epidemic’ amid rise in hospitalisations (The Independent)

• A Law will Prohibit the Sale of Nitrous Oxide or “Laughing Gas” to Minors in Bulgaria (Novinite.com)

Ketamine

• At Home Sublingual Ketamine Exhibits Rapid And Significant Antidepressant And Anxiolytic Effects (Medical Dialogues)

• Ketamine found to be unlikely to lead to addiction (Medical Xpress)

• Silo Pharma Announces Positive Results from its Topically Administered Formulation of Ketamine (Psychedelic Alpha)

Miscellaneous

• Biden Administration Plans For Legal Psychedelic Therapies Within Two Years (The Intercept)

• San Francisco Launches Bid to Decriminalize Psychedelics (Filter)

• Your Genes May Determine How You React To Psychedelic Drugs (IFLScience)

• The Psychoactive Substances Act on Trial (Volteface)

• The High-Stakes Race to Engineer New Psychedelic Drugs (WIRED)

• Trump Urges ‘Very Quick Trial’ and Death Penalty for Drug Dealers (High Times)

• The Psychedelics Industry’s Next Hurdle Is How to Go Mainstream (Bloomberg)

• One in four Americans say they’ve tried at least one psychedelic drug (YouGov)

• Microdosing: Scientists tackle psychedelic trend becoming ‘creative enhancer of choice’ (The Sydney Morning Herald)

Think Wilder is reader-supported. If you enjoyed this month’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 1.7.22

Cannabis

• Sadiq Khan plans pilot to ‘decriminalise’ minor cannabis offences in London (The Guardian)

• Legal recreational marijuana sales begin in Montana (KPAX)

• Federal Marijuana Monopoly Finally Ends As Two Companies Harvest Cannabis Approved By DEA (Marijuana Moment)

• New year rings in key changes to state marijuana markets (Marijuana Business Daily)

• GOP-Controlled New Hampshire House Votes To Legalize Marijuana Possession And Cultivation (Marijuana Moment)

• Colorado: Governor Issues Pardons to Over 1,300 Marijuana Offenders (NORML)

• Wyoming Marijuana Activists Turn Focus To 2024 Ballot For Decriminalization And Medical Cannabis Initiatives (Marijuana Moment)

• The top cannabis research studies of 2021 (Leafly)

• Incoming Virginia GOP Governor Won’t ‘Overturn’ Legal Marijuana Possession, But Casts Doubt On Sales (Marijuana Moment)

• Top Kansas Democrats Unveil Plan To Put Medical And Adult-Use Marijuana Legalization On The 2022 Ballot (Marijuana Moment)

• Two recreational marijuana initiatives might appear on Oklahoma ballot in fall (Marijuana Business Daily)

• Iowa Democrats Unveil Marijuana Resolution To Put Legalization On Ballot For Voters To Decide (Marijuana Moment)

• New Republican-Led Bill Would Legalize Medical Cannabis In Kentucky (Marijuana Moment)

• South Dakota Lawmakers Prepare Dozens Of Cannabis Reform Bills (High Times)

• Marijuana Decriminalization Reduces Arrests And Racial Disparities In Law Enforcement, Study Finds (Marijuana Moment)

• Tiny but mighty: Micro-cultivators dominated 2021 (Leafly)

• The cost of medical marijuana in Louisiana (KSLA)

• Israeli startup a go-to resource in medical cannabis world (I24News)

• Oklahoma Pot Farm Slapped with RICO From Next Door Neighbor (High Times)

• Cannabis users report higher quality of life than non-users (Leafie)

Magic Mushrooms

• Washington Psilocybin Bill Would Legalize Supported Adult Use (Bill of Health)

• COMP360 psilocybin study of 89 healthy participants published in Journal of Psychopharmacology (Psilocybin Alpha)

• New Hampshire Bipartisan Bills Want to Reduce Penalties on Psilocybin, Other Drugs (Truffle Report)

• Tryp Therapeutics Announces Advancement of Phase 2a Clinical Trial in Binge Eating Disorder (Psilocybin Alpha)

• Filament Health Announces Health Canada Approval for Phase II Trial Administering New Psilocybin Microdose Formulation (Psilocybin Alpha)

• Red Light Holland Psilocybin Truffles, Sold in The Netherlands, Complete Second Evaluation Under a Health Canada Approved cGMP Laboratory (Psilocybin Alpha)

• Psilocybin therapy options could expand in Hawaiʻi (Hawai'i Public Radio)

MDMA

• Drug testing: Dramatic drop in bath salts being sold as MDMA (Radio New Zealand)

• Microdosing MDMA: What Research Says About Doing It For Mental Health Issues (Healing Maps)

DMT

• Entheon Biomedical Provides Update on DMT Human Trial and Announces Regulatory Submission to Ethics Committee (Psilocybin Alpha)

Ayahuasca

• IRS defends denial of Des Moines church's tax-free status over use of psychedelic drug (KCCI)

• Anti-Drug GOP Senator Helps Psychedelic Church With Fight Against DEA And IRS (Marijuana Moment)

Iboga

• National Institute on Drug Abuse to Test Ibogaine For Addiction Treatment (Truffle Report)

• Caribbean Facility Finds Consistent Success Using Ibogaine for Anxiety and Trauma Treatment (PR Newswire)

Novel Psychoactive Substances

• MindMed Successfully Completes Phase 1 Clinical Trial of 18-MC (Psilocybin Alpha)

• Mindset Pharma Teams Up with The McQuade Center to Develop 2 Families of Novel Psychedelic Compounds (Psychedelic Spotlight)

Synthetic Cannabinoids

• Using cannabinoids to treat obesity (Medical Xpress)

• More needs to be done to tackle synthetic cannabinoids, experts say (Stuff.co.nz)

Ketamine

• Awakn Life Sciences Expands World's First Ketamine Study Beyond Gambling Disorder to Include Additional Behavioral Addictions (Yahoo!)

• PharmaTher Announces Publication of Research Data for KETABET™ (Psilocybin Alpha)

Miscellaneous

• The Promises and Perils of Psychedelic Health Care (The New York Times)

• Health Canada Grants Special Access to Restricted Drugs for Psychedelic Therapy (Psychedelic Spotlight)

• Magic mushroom companies are on the Nasdaq now. That’s a recipe for a bad trip (The Guardian)

• Psychedelics Can Change Your View on the Nature of Reality (Psychedelic Spotlight)

• Psychedelics in 2022: What to Expect (Truffle Report)

• Fact Check-London Mayor not decriminalising drugs (Reuters)

• Psychedelics 2021: A Year in Review (Psilocybin Alpha)

• Will overdose deaths force an end to the US ‘war on drugs’? (Financial Times)

• Philippines' Duterte says will never apologise for drug war deaths (Reuters)

• New York Prisons Punished 1,600 People for False Drug Test Results (Filter)

• Now psychedelics are coming to your medicine cabinet (ISRAEL21c)

• How Psychedelic Therapy Fuses Indigenous Shamanism With Western Science (IFLScience)

• Pop Culture Boosts Acceptance of Plant Medicine (GlobeNewswire)

• Can A Psychedelic Experience Improve 2022? (Reality Sandwich)

• Psychedelic Drug Policy Reform in 2021: A Year in Review (Psilocybin Alpha)

• Psychedelics Will Have a Big Presence at SXSW in 2022 (Psychedelic Spotlight)

• Was 2021 the Year Psychedelics Conquered Capitalism? (Green Entrepreneur)

• Startup To Host Psychedelic Trips In The Metaverse (Forbes)

• Is ‘The Trip’ Essential to The Psychedelic Experience? (Psychedelic Spotlight)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 12.24.21

Cannabis

• Analysis: Unregulated Delta-8 Vape Products Frequently Mislabeled, May Contain Heavy Metals (NORML)

• Malta Officially Legalizes Marijuana With President’s Signature, Becoming First In Europe To End Cannabis Prohibition (Marijuana Moment)

• Several States to Usher In the New Year with Cannabis Liberalization Laws (NORML)

• The Next States to Legalize Recreational Marijuana (MSN)

• Pfizer Bets On Medical Cannabis With $6.7 Billion Acquisition (Forbes)

• Scientists are (finally) studying how weed affects athletic performance and recovery (Leafly)

• New York Senator Files Bill To Extend Marijuana Equity Benefits To Gay, Lesbian And Bisexual People (Marijuana Moment)

• Cartels Ditch Pot and Opium Fields for Synthetic Drugs, Mexico Defense Secretary Says (High Times)

• Ohio: Citizens’ Petition Seeks to Compel Lawmakers to Hold Marijuana Legalization Vote (NORML)

• Senator Calls For Federal Marijuana Standard To Measure Impaired Driving (Marijuana Moment)

• Top Maryland Lawmaker Files Marijuana Legalization Referendum For 2022 Ballot (Marijuana Moment)

• Iowa Democrats Announce Plan To Let Voters Decide On Marijuana Legalization Amid GOP Resistance (Marijuana Moment)

• Whole-Plant Cannabis Extract Reduces Epileptic Seizures By 86% in Small Study (High Times)

• Researcher Uses Reddit To Learn What Kinds Of Marijuana Posts Influenced Legalization Attitudes (Marijuana Moment)

• Pair of Cops Booked After Being Caught Smoking Pot in Mississippi (High Times)

• Marijuana Group Releases ‘Robbery Preparedness Guide’ For Dispensaries Amid Spike In Thefts (Marijuana Moment)

• Dr. Sanjay Gupta adds to chorus of cannabis research on autism in 2021 (Leafly)

• Legal Cannabis Outsells Ontario Illicit Market for First Time (High Times)

• These were the weirdest weed news stories of 2021 (Leafly)

LSD

• U.S. FDA puts plans to test LSD in anxiety patients in clinical study on hold (Reuters)

Magic Mushrooms

• Canada’s Psilocybin Policy Reform Movement Continues to Make Progress Federally (Truffle Report)

• FDA Approves Psilocybin For Binge Eating Study By Tryp Therapeutics (Benzinga)

Ayahuasca

• Global ayahuasca trend drives deforestation in Brazil’s Acre state (Mongabay)

Morning Glory Seeds

• Study shows common flower species holds promise for beneficial psychedelic drugs (Newswise)

Ketamine

• Ketamine Therapy Quickly Reduces Depression and Suicidal Thoughts (SciTechDaily)

DXM

• Cough medicine creates dangerous interaction (The Seattle Times)

Miscellaneous

• Port Townsend Becomes 13th City to Decriminalize Psychedelics (DoubleBlind)

• Psychedelics: The newest tool in nuclear negotiations? (Bulletin of the Atomic Scientists)

• How Should Psychedelic Medicine Handle “Flashbacks”? (Mad in America)

• New center to study psychedelics pops up at University of Texas at Austin (My San Antonio)

• The Dumbest Drug Scare Stories of 2021 (VICE)

• DEA Wants To Help Parents Decode The Emojis Young People Use To Discuss Marijuana And Other ‘Bomb Ass’ Drugs (Marijuana Moment)

• GOP Lawmakers File Bills To Streamline Research Into Marijuana, Psychedelics And Other Schedule I Drugs (Marijuana Moment)

• Colorado Ballot Initiatives Filed to Legalize Psychedelics (Truffle Report)

• Two Leaders in Psychedelics Industry and the Harm Reduction Approach (Nasdaq)

• How Do Hallucinogenic Drugs Change Our Personality? (Psychology Today)

• Microdosing companion app Houston wants to be your guide to 'inner space' (Mashable)

• Why Psychedelic Research May Bring the Next Big Breakthrough in Dementia Treatment (Psychedelic Spotlight)

• MYND Life Sciences Acquires Rights for the Use of Psychedelics to Treat Alzheimer’s Disease and other Dementias (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 11.19.21

Cannabis

• U.S. Republicans move to decriminalize marijuana at federal level (Reuters)

• Germany Set To Legalize Marijuana Nationwide After Major Parties Reach Agreement (Marijuana Moment)

• Brazil is on The Brink of Medical Cannabis Change (High Times)

• Is This The First Real Case Of Fentanyl-Tainted Marijuana In The U.S.? (Forbes)

• Indiana Democratic Party Backs Marijuana Legalization And Pledges 2022 Reform Push (Marijuana Moment)

• New York Senator Files Bill To Extend Marijuana Equity Benefits To Transgender And Non-Binary People (Marijuana Moment)

• Straws Lined with THC Could Transform Edibles Industry (High Times)

• Bipartisan Wisconsin Lawmakers Unveil Marijuana Decriminalization Bill (Marijuana Moment)

• New study shows no increase in car crash injuries after marijuana legalized (Vancouver Sun)

• Canadian Groups Gives Free Weed And Edibles To Fight Opioid Abuse (High Times)

• Marijuana Legalization Attitudes Vary Significantly Within Partisan Coalitions, Pew Survey Shows (Marijuana Moment)

• Creating a better cannabis cultivation facility while strengthening relationships with third-party testing labs (Marijuana Business Daily)

• Sturdy Hemp Structures Could be the Future Eco-Building (High Times)

• Using cannabis in pregnancy linked to aggression and anxiety in children, a study suggests (CNN)

• Study: Scarification of cannabis seeds, certain disinfectants boost germination rates (Marijuana Business Daily)

LSD

• MindMed Launches Study of Low-Dose LSD Effects on Sleep and Cognitive Measures (Psilocybin Alpha)

• Up, Up and Away: The Trippy Tales Behind ‘Flying Over Sunset’ (The New York Times)

• Is LSD Safe - Latest Research Findings (Drug Science)

• The LSD Comedown: Navigating the After Effects of Acid (DoubleBlind)

Magic Mushrooms

• Bill on magic mushrooms aims to make Pa. a national leader in psychedelic research (The Philadelphia Inquirer)

• NYC Subways Ban Marijuana And Psychedelic Mushroom Ads (Marijuana Moment)

• Magic Mushrooms, A Love Story (The New Yorker)

• PharmaTher Announces Positive Research Results for Psilocybin Microneedle Patch (Psilocybin Alpha)

• Tryp Therapeutics Provides Update on Clinical Hold for Phase 2a Study for Eating Disorders (Yahoo!)

• TheraPsil and Imperial College London, McGill University Partner on Psilocybin Study (Truffle Report)

• Red Light Holland Psilocybin Truffles, Sold in The Netherlands, Complete First Evaluation Under a Health Canada Approved cGMP Laboratory (Psilocybin Alpha)

• Another Life: Foraging for mushrooms and natural psychedelics (The Irish Times)

MDMA

• World's 'Strongest-Ever' Ecstasy Pill Found in English Nightclub (VICE)

DMT

• Algernon Announces Positive Feedback on its Planned Phase 1/2a DMT Human Stroke Study (Yahoo!)

• Discussions With FDA Provide Guidance for Phase IIb Clinical Trial Design for DMT-Assisted Therapy for Major Depressive Disorder (Psilocybin Alpha)

Ayahuasca

• Is This Phoenix Pastor a Spiritual Shaman or an Ayahuasca Kingpin — or Both? (Phoenix New Times)

• Ron White’s strange ayahuasca experience, as described on JRE. (Ceng News)

5-MeO-DMT

• Mike Tyson ‘died’ while tripping on psychedelic toad venom (New York Post)

• Biomind Labs Completes Development of a Thermosensitive Nasal Gel Pharmaceutical Dosage Form (Business Wire)

Novel Psychoactive Substances

• New Psychedelic Molecules: What’s in Development? (Truffle Report)

• New Psychedelic Molecules Part II: Key Industry Players (Truffle Report)

• Researchers train computers to predict the next designer drugs (ScienceDaily)

• BetterLife Pharma says pharmacology data on second-generation LSD derivative confirms its projected non-hallucinogenic property (Proactive Investors)

Ketamine

• Michael J. Fox Foundation Grant Will Fund First Clinical Trial of Ketamine to Treat Depression in People with Parkinson’s Disease (Yale School of Medicine)

• Warning of ‘wild west’ in depression treatment as UK clinics offer ketamine (The Guardian)

• Bexson Biomedical Announces Expansion to Treat Major Depression with Wearable Ketamine Formulation (PR Newswire)

• Silo Pharma and Strategic Partner Zylo Therapeutics Begin Development Process for Novel Ketamine Loaded Z-Pods (Psilocybin Alpha)

DXM

• Teenagers are ‘robotripping’ in the pursuit of cheap highs, again (Screenshot Media!)

Miscellaneous

• Jon Hopkins’s Psychedelic Journey to a New Way of Creating Music (The New York Times)

• "Aharon said it was healing:" How psychedelic therapy was undermined by abuse (Inverse)

• Psychedelics Use Associated With 55 Percent Decrease In Daily Opioid Consumption, Study Finds (Marijuana Moment)

• Horizons Conference Reconvenes in NYC to Connect Psychedelic Communities (Lucid News)

• New Non-Profit Supports Groundbreaking HPPD or ‘Acid Flashback’ Research (Truffle Report)

• Inside The Race To Create A Two-Hour Psychedelic Therapy Experience (Forbes)

• Psychedelics Help Heal Childhood Trauma, Study Finds (Benzinga)

• Psychedelic Bypassing: When Avoidance is Mistaken for Healing (Psychedelics Today)

• Canadian Biotech Known For Psilocybin And Cannabinoid-Based Medicines In FDA Phase 3 Trial For Bucillamine-Based Oral Covid Treatment (Forbes)

• Three Decades of Drug Policy Reform Work (Open Society Foundations)

• A Close Reading of the QAnon Shaman’s Conspiracy Manifesto (Lit Hub)

• Naropa University Announces Psychedelic-Assisted Therapies Certificate (Tricycle)

• A New Psychedelic Organization is Merging Shamanism and Science (Lucid News)

• The Serotonin 5-HT2A Receptor: From Mice to Humans (Psychedelic Science Review)

• Animals That Eat Psychedelics and Enjoy the Trip (Psychedelic Spotlight)

• CaaMTech Teams Up With University of Wyoming to Study Psychedelics as Treatments for Addiction (Psilocybin Alpha)

• MYND Diagnostics Commences Clinical Research on Alzheimer’s Disease (Psilocybin Alpha)

• Letting people test their drugs will reduce the number of needless deaths (The Independent)

• The History of Psychedelics: An ancient tradition (Canex)

• MYND Diagnostics Commences Clinical Research on Multiple Sclerosis Biomarker Test (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 10.22.21

Cannabis

• Luxembourg first in Europe to legalise growing and using cannabis (The Guardian)

• Switzerland to legalise recreational and medical cannabis usage (The Local)

• Virginia Has Sealed 64,000 Marijuana Distribution Charges Since Legalization Took Effect This Summer (Marijuana Moment)

• New York: Employers Are Prohibited from Testing Most Employees for Cannabis (NORML)

• Top Mexican Senator Says Marijuana Legalization Bill May Be Taken Up Within Weeks (Marijuana Moment)

• South Dakota Lawmakers Advance Marijuana Legalization Bill As Activists Pursue 2022 Ballot Initiative (Marijuana Moment)

• Oregon illegal pot grows: More calls to send National Guard (AP News)

• USPS Releases Final Rule Banning Mailing Of Hemp, CBD And Marijuana Vapes (Marijuana Moment)

• Alabama Announces Medical Cannabis Licenses Won’t Be Available Until 2022 (High Times)

• Impact Of Marijuana Legalization On Crime Reduction Is Being Underestimated, New Study Finds (Marijuana Moment)

• Recreational Cannabis Law in Washington, D.C. May Soon Be Operational (High Times)

• New York: Officials Advance Home Cultivation Regulations for Qualified Patients (NORML)

• Minnesota Denies Coverage of Medical Marijuana for Injured Workers (High Times)

• Brit jailed for 25 years in Dubai over CBD vape oil speaks of 'shocking' conditions in call to mum (ITV)

• Indica and Sativa Labels Can’t Be Trusted, Study Indicates (High Times)

• Americans Want To Live Where Marijuana Is Legal, Real Estate Survey Finds (Marijuana Moment)

• Study: Cannabis Use Benefits ADHD Symptoms in Adults, According to Self-Reports (ADDitude)

LSD

• LSD vs. Psilocybin Microdosing for Mental Health and Workplace productivity (The Third Wave)

• Can You Overdose On LSD? This Is What To Know (Healing Maps)

Magic Mushrooms

• Boris Johnson to consider calls to legalise magic mushroom drug psilocybin (BBC)

• Open-label study of COMP360 psilocybin therapy for depression in cancer patients demonstrates feasibility of simultaneous psilocybin administration in small groups (Psilocybin Alpha)

• COMPASS Pathways is granted new US patent for crystalline psilocybin (Psilocybin Alpha)

• Doing Shrooms Alone: The Art of Tripping Solo (DoubleBlind)

• Psyched Wellness Announces Preliminary Data Showing Potential New Functional Property and Health Benefit of Amanita Muscaria Mushroom (AME-1) To Inhibit Human Mast Cell Activation (Psilocybin Alpha)

• The “Unsung History” of Psilocybin Research: Gastón Guzmán and His Scientific Contribution (Chacruna)

• Numinus Advances Phase 1 Trial on Proprietary Psilocybin Product (Psilocybin Alpha)

• Magic Mushrooms Could One Day Treat Depression. How Do They Work? (ScienceAlert)

MDMA

• Treating Hypoactive Sexual Disorder With MDMA (Reality Sandwich)

DMT

• First Patient Dosed in Phase IIa DMT-Assisted Therapy Clinical Trial (Psilocybin Alpha)

• Small Pharma Granted Fast-Track Designation From U.K. Regulator for DMT-Assisted Therapy for Major Depressive Disorder (Psilocybin Alpha)

Novel Psychoactive Substances

• Cybin Announces Completion of 74 Pre-Clinical Psychedelic Molecule Studies (Psilocybin Alpha)

• Emyria passes MDMA analogue development milestone with Eurofins to lead extensive compound screening program (Proactive Investors)

Nitrous Oxide

• Nang gang: Nitrous oxide helps alleviate depression, study finds (The Big Smoke)

Ketamine

• Are Ketamine Clinics Paving the Way for Legal Psychedelic Therapy? (DoubleBlind)

• Why Ketamine-Assisted Therapy Has Gone Mainstream (Forbes)

• PharmaTher Engages Alcami for Clinical and Commercial Manufacturing of Novel Ketamine Products (Psilocybin Alpha)

Miscellaneous

• Easthampton, Mass. Decriminalizes Natural Psychedelics (DoubleBlind)

• Oakland Psychedelics Activists Launch Initiative To Legalize Community-Based Sales With Support From City Council (Marijuana Moment)

• DEA Proposes Dramatic Increase In Marijuana And Psychedelic Production In 2022, Calling For 6,300 Percent More MDMA Alone (Marijuana Moment)

• Preventing Sexual Abuse in Psychedelic Therapy (Psychedelic Spotlight)

• Bank Of America Cancels Account Of Marijuana And Psychedelics Research Institute Registered With DEA (Marijuana Moment)

• Activist Apes Erect 2,001-Pound Monolith In Front Of DEA Headquarters, Demanding Feds ‘Evolve’ On Drug Policy (Marijuana Moment)

• How Do I Talk To My Doctor About Psychedelics? (Truffle Report)

• Addressing Abuse and Repair: An Open Letter to the Psychedelic Community (Chacruna)

• This New Company Believes Psychedelics Can Treat Dementia (Psychedelic Spotlight)

• Campaign Launches to Decriminalize Drugs in Washington, DC (Filter)

• Can microdosing psychedelics impact an insurance application? (News24)

• Even in a Year of Massive Reforms, Racist Myths Pervade the Drug Policy Debate (TalkingDrugs)

• Countdown to ecstasy: how music is being used in healing psychedelic trips (The Guardian)

• Homecoming: The Psychedelic Digital Companion Therapists Are Already Using (Forbes)

• The Whitewashing of Psychedelic Medicine (Reality Sandwich)

• Field Trip Health Ltd. Continues Expansion With Psychedelic-Assisted Therapy Centers in Seattle, Vancouver and Fredericton (Psilocybin Alpha)

• Baltimore Study Boosts Movements to Decriminalize Drugs and Sex Work (Filter)

• Carlos Santana still takes hallucinogens (MSN)

• ‘Shrooms! Shamans! Kosher LSD! Why Los Angeles Is Suddenly Tripping Out (Los Angeles Magazine)

• How Nutrition Can Improve the Psychedelic Experience (Psychedelic Spotlight)

• Why creatives should microdose LSD and cannabis before big pitches (AdAge)

• Psychedelics and Sports: Can They Propel Athletes to Unprecedented Pinnacles of Ability? (Psychedelic Spotlight)

• Tryp Therapeutics Reports Clinical Hold on Proposed Phase 2a Study in Eating Disorders (Psilocybin Alpha)

• The Neuroanatomy of a Psychedelic Trip: The Basics (Healing Maps)

• atai Life Sciences Launches atai Impact, a Philanthropic Program to Harness the Power of Innovative Mental Health Approaches for Positive Social Change (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.